12/05/2014 - 15:45
ALBUQUERQUE – Adding topical tazarotene did not improve response to 5% imiquimod in lentigo maligna, based on data from nearly 300 patients.
But patients with higher levels of inflammation in...
Field of Interest: Oncology
Categories:
News Feed: Internal Medicine News - Oncology